Cagrilintide

Cagrilintide is an investigational long-acting amylin analogue being studied for its potential effects on appetite regulation, food intake, and metabolic health. By mimicking key actions of the naturally occurring hormone amylin, cagrilintide is designed to influence pathways involved in satiety and energy balance.

Clinical research has evaluated cagrilintide both as a standalone investigational therapy and in combination with other metabolic agents, with studies examining its potential effects on body weight, appetite, and glycemic control.

Important Note: Cagrilintide is intended for research purposes only and should not be used for human consumption or self-administration. Always ensure compliance with local regulations when handling peptides.